CTRI Number |
CTRI/2022/09/045277 [Registered on: 07/09/2022] Trial Registered Prospectively |
Last Modified On: |
09/10/2022 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda |
Study Design |
Single Arm Study |
Public Title of Study
|
Study of Yashada bhasma in healthy human volunteers |
Scientific Title of Study
|
Pharmaceutical-Analytical study of Yashada bhasma and its estimation in serum of healthy human volunteers |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Veda SM |
Designation |
PG scholar |
Affiliation |
Government Ayurvedic Medical College, Bangalore |
Address |
Dept of RSBK,
GAMC,Bangalore
Bangalore KARNATAKA 560009 India |
Phone |
8762532179 |
Fax |
|
Email |
vedasosale@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Surekha S Medikeri |
Designation |
Proffessor & HOD |
Affiliation |
RGUHS |
Address |
Dept of RSBK,
GAMC, Bangalore
Bangalore KARNATAKA 560009 India |
Phone |
9449134112 |
Fax |
|
Email |
surekhamedikeri@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Vidya Sagar GV |
Designation |
Associate Proffessor |
Affiliation |
RGUHS Sciences |
Address |
Dept. of Biochemistry
Kempegowda Institute of Medical Sciences,
Bangalore
Bangalore KARNATAKA 560070 India |
Phone |
9880007900 |
Fax |
|
Email |
drgvvsagar@gmail.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
Veda SM |
Address |
PG Scholar,
GAMC, Bangalore |
Type of Sponsor |
Other [Self] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Veda SM |
Govt. Ayurvedic Medical College & Hospital (GAMC), Bangalore |
Room No. 7D,
Department of RSBK Bangalore KARNATAKA |
8762532179
vedasosale@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
IEC GAMC Bangalore |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Healthy Human Volunteers |
Healthy Human Volunteers |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Yashada Bhasma, Reference: Rasatarangini, Route: Oral, Dosage Form: Bhasma, Dose: 250(mg), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 1 Days, anupAna/sahapAna: Yes(details: water), Additional Information: - |
|
|
Inclusion Criteria
|
Age From |
20.00 Year(s) |
Age To |
40.00 Year(s) |
Gender |
Both |
Details |
Healthy volunteers from both genders aged between 20 to 40 years, free of any ailments and doing routine activities. |
|
ExclusionCriteria |
Details |
1. Any subjects with diseases / disorders.
2. Pregnancy and lactation,
3. Sports persons,
4. physical exercising,
5. mental disorders,
6. alcoholics and drug abuse.
7. Consumption of zinc supplements. |
|
Method of Generating Random Sequence
|
Other |
Method of Concealment
|
Pharmacy-controlled Randomization |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Zinc level at different intervals. Zinc levels in serum increases gradually, reaches peak and declines. |
0, 1st hr, 2nd hr, 3rd hr, 4th hr, 5th hr, 6th hr, 7th hr. |
|
Secondary Outcome
|
Outcome |
TimePoints |
Blood Pressure before and after supplementation of Yashada Bhasma. |
0hr and after 7th Hr. |
|
Target Sample Size
|
Total Sample Size="20" Sample Size from India="20"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 3/ Phase 4 |
Date of First Enrollment (India)
|
08/09/2022 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Closed to Recruitment of Participants |
Publication Details
|
Nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
The study will comprise of 20 healthy volunteers aged between 20 – 40 years after a written informed consent. The blood samples will be collected at 0, 1, 2, 3, 4, 5, 6 and 7 hours of supplementing 250 mg of Yashada bhasma. Serum Zinc levels are estimated with the above samples.
|